Published in Appl Environ Microbiol on September 01, 2001
Strategies for successful recombinant expression of disulfide bond-dependent proteins in Escherichia coli. Microb Cell Fact (2009) 1.72
Strategies for the recovery of active proteins through refolding of bacterial inclusion body proteins. Microb Cell Fact (2004) 1.64
Use of folding modulators to improve heterologous protein production in Escherichia coli. Microb Cell Fact (2009) 1.00
Reducing conditions are the key for efficient production of active ribonuclease inhibitor in Escherichia coli. Microb Cell Fact (2011) 0.91
Effect of culture medium, host strain and oxygen transfer on recombinant Fab antibody fragment yield and leakage to medium in shaken E. coli cultures. Microb Cell Fact (2013) 0.90
Ability of Lactococcus lactis to export viral capsid antigens: a crucial step for development of live vaccines. Appl Environ Microbiol (2003) 0.89
Twin-arginine translocation of active human tissue plasminogen activator in Escherichia coli. Appl Environ Microbiol (2005) 0.89
Studies of single-chain antibody expression in quiescent Escherichia coli. Appl Environ Microbiol (2004) 0.88
Expression of active recombinant human tissue-type plasminogen activator by using in vivo polyhydroxybutyrate granule display. Appl Environ Microbiol (2010) 0.80
Cellular disulfide bond formation in bioactive peptides and proteins. Int J Mol Sci (2015) 0.78
Structural and Functional Characterization of Recombinant Interleukin-10 from Indian Major Carp Labeo rohita. J Immunol Res (2016) 0.75
The Hsp70 and Hsp60 chaperone machines. Cell (1998) 13.79
Successive action of DnaK, DnaJ and GroEL along the pathway of chaperone-mediated protein folding. Nature (1992) 5.92
Small heat shock proteins are molecular chaperones. J Biol Chem (1993) 5.62
DnaK, DnaJ and GrpE form a cellular chaperone machinery capable of repairing heat-induced protein damage. EMBO J (1993) 4.32
Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm. Proc Natl Acad Sci U S A (1999) 3.60
The nucleotide sequence of the Escherichia coli K12 dnaJ+ gene. A gene that encodes a heat shock protein. J Biol Chem (1986) 3.04
Binding of non-native protein to Hsp25 during heat shock creates a reservoir of folding intermediates for reactivation. EMBO J (1997) 2.92
Purification and properties of the dnaJ replication protein of Escherichia coli. J Biol Chem (1985) 2.84
High-level expression of recombinant genes in Escherichia coli is dependent on the availability of the dnaY gene product. Gene (1989) 2.63
Secretion cloning vectors in Escherichia coli. EMBO J (1984) 2.58
Disulfide bond formation in the Escherichia coli cytoplasm: an in vivo role reversal for the thioredoxins. EMBO J (1998) 2.56
In vitro folding of inclusion body proteins. FASEB J (1996) 2.40
Structural and functional characterization of DsbC, a protein involved in disulfide bond formation in Escherichia coli. Biochemistry (1995) 2.33
A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma. Thromb Haemost (1982) 2.22
Cellular location affects protein stability in Escherichia coli. Proc Natl Acad Sci U S A (1982) 2.20
The genetics of disulfide bond metabolism. Annu Rev Genet (1998) 2.17
Protein folding in the bacterial periplasm. J Bacteriol (1997) 2.11
Building bridges: disulphide bond formation in the cell. Mol Microbiol (1994) 1.83
Advances in refolding of proteins produced in E. coli. Curr Opin Biotechnol (1998) 1.75
In vitro and in vivo redox states of the Escherichia coli periplasmic oxidoreductases DsbA and DsbC. Biochemistry (1997) 1.56
In vivo and in vitro function of the Escherichia coli periplasmic cysteine oxidoreductase DsbG. J Biol Chem (1999) 1.51
Expression of active human tissue-type plasminogen activator in Escherichia coli. Appl Environ Microbiol (1998) 1.47
Inhibition of aggregation side reactions during in vitro protein folding. Methods Enzymol (1999) 1.45
Differential in vivo roles played by DsbA and DsbC in the formation of protein disulfide bonds. J Biol Chem (1997) 1.42
In vivo control of redox potential during protein folding catalyzed by bacterial protein disulfide-isomerase (DsbA). J Biol Chem (1993) 1.35
Molecular cloning, sequencing and expression in Escherichia coli of the 25-kDa growth-related protein of Ehrlich ascites tumor and its homology to mammalian stress proteins. Eur J Biochem (1989) 1.31
Leaderless polypeptides efficiently extracted from whole cells by osmotic shock. J Bacteriol (1997) 1.22
Localization of inclusion bodies in Escherichia coli overproducing beta-lactamase or alkaline phosphatase. Appl Environ Microbiol (1986) 1.07
High-level production and long-term storage of engineered antibodies in transgenic tobacco seeds. Biotechnology (N Y) (1995) 1.00
Biochemical properties of the kringle 2 and protease domains are maintained in the refolded t-PA deletion variant BM 06.022. Protein Eng (1992) 0.98
Elimination of all charged residues in the vicinity of the active-site helix of the disulfide oxidoreductase DsbA. Influence of electrostatic interactions on stability and redox properties. J Biol Chem (1997) 0.98
Molecular basis of fibrinolysis, as relevant for thrombolytic therapy. Thromb Haemost (1995) 0.89
The effect of molecular chaperones on in vivo and in vitro folding processes. Biol Chem (1997) 0.82
Effect of modification of connecting peptide of proinsulin on its export. J Biotechnol (1994) 0.80
Selection for signal sequence mutations that enhance production of secreted human proinsulin by Escherichia coli. Gene (1988) 0.78
Analysis of membrane and surface protein sequences with the hydrophobic moment plot. J Mol Biol (1984) 13.69
Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature (1985) 11.11
Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J (1986) 7.60
DNA sequence and genome organization of genital human papillomavirus type 6b. EMBO J (1983) 5.42
Nucleotide sequence of cro, cII and part of the O gene in phage lambda DNA. Nature (1978) 4.12
The nucleotide sequence and genome organization of human papilloma virus type 11. Virology (1986) 4.04
Cell-type-specific markers for distinguishing and studying neurons and the major classes of glial cells in culture. Brain Res (1979) 3.66
GroE facilitates refolding of citrate synthase by suppressing aggregation. Biochemistry (1991) 2.92
Markedly elevated levels of interferon (IFN)-gamma, IFN-alpha, interleukin (IL)-2, IL-10, and tumor necrosis factor-alpha associated with fatal Ebola virus infection. J Infect Dis (1999) 2.76
Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3) J Clin Invest (2000) 2.57
Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci U S A (1987) 2.40
Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience (1994) 2.36
Functional analysis of the replicator structure of lambdoid bacteriophage DNAs. Cold Spring Harb Symp Quant Biol (1979) 2.18
Capsaicin-induced ion fluxes in dorsal root ganglion cells in culture. J Neurosci (1988) 2.18
Respiratory medicine: fighting for survival. BMJ (1992) 2.15
Mdj1p, a novel chaperone of the DnaJ family, is involved in mitochondrial biogenesis and protein folding. Cell (1994) 2.12
Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br J Pharmacol (1995) 2.12
Molecular cloning of integrin-associated protein: an immunoglobulin family member with multiple membrane-spanning domains implicated in alpha v beta 3-dependent ligand binding. J Cell Biol (1993) 2.10
Antimicrobial resistance and R-factor transfer among isolates of Salmonella in the northeastern United States: a comparison of human and animal isolates. J Infect Dis (1975) 2.09
MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation. Nat Genet (2001) 2.04
Genetic interactions of modifier genes and modifiable alleles in Drosophila melanogaster. Genetics (1988) 1.99
Outbreak of Legionnaires' disease in Glasgow Royal Infirmary: microbiological aspects. J Hyg (Lond) (1986) 1.99
Myelin-specific proteins and glycolipids in rat Schwann cells and oligodendrocytes in culture. J Cell Biol (1980) 1.98
Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr (1992) 1.89
Correlation of modified human papilloma virus early gene expression with altered growth properties in C4-1 cervical carcinoma cells. Cancer Res (1988) 1.89
Renaturation, purification and characterization of recombinant Fab-fragments produced in Escherichia coli. Biotechnology (N Y) (1991) 1.88
A kinetic study of the competition between renaturation and aggregation during the refolding of denatured-reduced egg white lysozyme. Biochemistry (1991) 1.83
Two distant clusters of partially homologous small repeats of Epstein-Barr virus are transcribed upon induction of an abortive or lytic cycle of the virus. J Virol (1983) 1.82
A gene coding for tRNA is located near 5' terminus of 16S rRNA gene in Zea mays chloroplast genome. Proc Natl Acad Sci U S A (1981) 1.81
Complete degradation of carbohydrate to carbon dioxide and methane by syntrophic cultures of Acetobacterium woodii and Methanosarcina barkeri. Arch Microbiol (1979) 1.79
Nucleotide sequence of the cro-cII-oop region of bacteriophage 434 DNA. Nucleic Acids Res (1979) 1.78
First evidence of pep solar neutrinos by direct detection in Borexino. Phys Rev Lett (2012) 1.77
Cerebral metabolism and atrophy in Huntington's disease determined by 18FDG and computed tomographic scan. Ann Neurol (1982) 1.77
NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J Immunol (2001) 1.76
Peripheral nerve injury induces cannabinoid receptor 2 protein expression in rat sensory neurons. Neuroscience (2005) 1.76
Advances in refolding of proteins produced in E. coli. Curr Opin Biotechnol (1998) 1.75
The glucose kinase gene of Streptomyces coelicolor A3(2): its nucleotide sequence, transcriptional analysis and role in glucose repression. Mol Microbiol (1992) 1.72
Respiratory syncytial virus G and/or SH protein alters Th1 cytokines, natural killer cells, and neutrophils responding to pulmonary infection in BALB/c mice. J Virol (1999) 1.71
Platelet-derived growth factor-BB and transforming growth factor beta 1 selectively modulate glycosaminoglycans, collagen, and myofibroblasts in excisional wounds. Am J Pathol (1991) 1.69
Protein aggregation in vitro and in vivo: a quantitative model of the kinetic competition between folding and aggregation. Biotechnology (N Y) (1991) 1.65
Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia. Placenta (2000) 1.64
A rat model of bone cancer pain. Pain (2002) 1.61
Fluorescence in situ hybridization shows spatial distribution of as yet uncultured treponemes in biopsies from digital dermatitis lesions. Microbiology (1998) 1.55
DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer. Oncogene (2009) 1.53
Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole. Bone Marrow Transplant (2007) 1.51
Computerized chest tomography in asbestos workers suspected of having pleural disease. J Natl Med Assoc (1987) 1.50
Reconstitution of lactic dehydrogenase. Noncovalent aggregation vs. reactivation. 1. Physical properties and kinetics of aggregation. Biochemistry (1979) 1.49
Complications in endoscopy of the lower gastrointestinal tract. Therapy and prognosis. Surg Endosc (1994) 1.48
A dibasic motif in the tail of a class XIV apicomplexan myosin is an essential determinant of plasma membrane localization. Mol Biol Cell (2000) 1.48
Refolding and association of oligomeric proteins. Methods Enzymol (1986) 1.47
VR1 protein expression increases in undamaged DRG neurons after partial nerve injury. Eur J Neurosci (2001) 1.46
Pathology of 12 fatal cases of Argentine hemorrhagic fever. Am J Trop Med Hyg (1973) 1.45
Inhibition of aggregation side reactions during in vitro protein folding. Methods Enzymol (1999) 1.45
Dietary intake in patients with acquired immunodeficiency syndrome (AIDS), patients with AIDS-related complex, and serologically positive human immunodeficiency virus patients: correlations with nutritional status. JPEN J Parenter Enteral Nutr (1991) 1.44
Major outer membrane protein of Campylobacter fetus: physical and immunological characterization. Infect Immun (1976) 1.43
The ultrastructure of chronic radiation damage in rat skin. Surg Gynecol Obstet (1981) 1.43
[Multiple chemical sensitivity disorder in patients with neurotoxic illnesses]. Gesundheitswesen (1996) 1.42
Characterization of a novel human papillomavirus DNA in the cervical carcinoma cell line ME180. J Virol (1991) 1.42
How long after neutrophil recovery should myeloid growth factors be continued in autologous hematopoietic stem cell transplant recipients? Bone Marrow Transplant (2004) 1.41
[Acute mitral insufficiency in osteogenesis imperfecta]. Dtsch Med Wochenschr (1994) 1.41
Purification and use of Methanobacterium wolfei pseudomurein endopeptidase for lysis of Methanobacterium thermoautotrophicum. J Bacteriol (1987) 1.40
Interferon alpha-2a and 13-cis-retinoic acid in patients with metastatic renal cell cancer. Cancer Invest (2000) 1.39
A modest proposal to (maybe) avoid cervical disc disease. Plast Reconstr Surg (1998) 1.39
A gene for inherited cutaneous venous anomalies ("glomangiomas") localizes to chromosome 1p21-22. Am J Hum Genet (1999) 1.37
Hydrolysis of dietary flavonoid glycosides by strains of intestinal Bacteroides from humans. Biochem J (1987) 1.36
Pharmacological differences between the human and rat vanilloid receptor 1 (VR1). Br J Pharmacol (2001) 1.35
Isolation and characterization of human fecal bacteria capable of 21-dehydroxylating corticoids. Appl Environ Microbiol (1977) 1.35
Fournier's syndrome: synergistic gangrene of the scrotum. Am J Surg (1975) 1.35
Reconstitution of a heat shock effect in vitro: influence of GroE on the thermal aggregation of alpha-glucosidase from yeast. Biochemistry (1991) 1.34
Degradation of steroids in the human gut. J Lipid Res (1983) 1.32
Tumor induction by human adenovirus type 12 in hamsters: loss of the viral genome from adenovirus type 12-induced tumor cells is compatible with tumor formation. EMBO J (1982) 1.31
Capsaicin sensitivity is associated with the expression of the vanilloid (capsaicin) receptor (VR1) mRNA in adult rat sensory ganglia. Neurosci Lett (1998) 1.29
mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia. Neuropharmacology (2001) 1.28
Analysis of the reconstitution of oligomeric enzymes by cross-linking with glutaraldehyde: kinetics of reassociation of lactic dehydrogenase. Biochemistry (1981) 1.28
The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin. J Med Chem (1994) 1.28
Localisation of cannabinoid receptor 1 in rat dorsal root ganglion using in situ hybridisation and immunohistochemistry. Neuroscience (2003) 1.27
Antimicrobial resistance of Shigella isolated in New York City in 1973. Antimicrob Agents Chemother (1975) 1.26
Nerve growth factor (NGF) differentially regulates the chemosensitivity of adult rat cultured sensory neurons. J Neurosci (1995) 1.26
[Effect of L-malate on glucose fermentation by Leuconostoc mesenteroides]. Arch Mikrobiol (1973) 1.26
Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds. J Clin Invest (1995) 1.25
The N-terminal fragment of human parathyroid hormone receptor 1 constitutes a hormone binding domain and reveals a distinct disulfide pattern. Biochemistry (2000) 1.23
Molecular cloning and partial nucleotide sequence of human papillomavirus type 1a DNA. Virology (1982) 1.22
Oral health status and oral health behaviors in Chinese Children. J Dent Res (2001) 1.22
Retinal ganglion cells lose response to laminin with maturation. Nature (1986) 1.22
The pro-sequence facilitates folding of human nerve growth factor from Escherichia coli inclusion bodies. Eur J Biochem (2001) 1.22
[Free amino acids and other ninhydrin-positive substances in the normal horny layer and in psoriasis scales]. Arch Klin Exp Dermatol (1967) 1.21
[Psoriasis vulgaris. On solubility]. Arch Klin Exp Dermatol (1966) 1.21
Utilization of dental services in Southern China. J Dent Res (2001) 1.21
The role of laminin and the laminin/fibronectin receptor complex in the outgrowth of retinal ganglion cell axons. Dev Biol (1987) 1.20
Nucleotide sequence and functional properties of a sodium-dependent citrate transport system from Klebsiella pneumoniae. J Biol Chem (1992) 1.20
Safety and feasibility of long-term temozolomide treatment in patients with high-grade glioma. Neurology (2007) 1.20
Bacterial intracranial aneurysms. J Neurosurg (1980) 1.19
Reversible high-pressure dissociation of lactic dehydrogenase from pig muscle. Biochemistry (1980) 1.19
Characterization of novel antimicrobial peptoids. Antimicrob Agents Chemother (1999) 1.19
Steroids and apparent cerebral atrophy on computed tomography scans. J Comput Assist Tomogr (1978) 1.17